![Michael Kamarck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kamarck
No open positions remaining
Profile
Currently, Michael E. Kamarck occupies the position of Chief Technology Officer for Vir Biotechnology, Inc. Dr. Kamarck is also on the board of Trillium Therapeutics, Inc. and Unilife Medical Solutions, Inc. and Member of TransForm Pharmaceuticals, Inc. In the past he held the position of SVP-Global Vaccines & Biologics Manufacturing at Merck & Co., Inc. and President of Merck BioVentures (a subsidiary of Merck & Co., Inc.), Head-Therapeutic Monoclonal Antibodies at Sanofi, President-Technical Operations & Product Supply at Wyeth Pharmaceuticals, Inc. and Principal at Willow Creek Biotech Consulting LLC. He received an undergraduate degree from Oberlin College and a doctorate from Massachusetts Institute of Technology.
Former positions of Michael Kamarck
| Companies | Position | End |
|---|---|---|
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 2023-06-29 |
| VAXCYTE, INC. | Director/Board Member | 2023-06-29 |
| PASSAGE BIO, INC. | Director/Board Member | 2023-06-29 |
| TRILLIUM THERAPEUTICS | Director/Board Member | 2021-11-16 |
| UNILIFE CORPORATION | Director/Board Member | 2017-10-25 |
Training of Michael Kamarck
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
56
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Unilife Corp.
 Unilife Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets syringes & other medical devices | Health Technology |
Oberlin College
 Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Unilife Medical Solutions, Inc.
 Unilife Medical Solutions, Inc. Medical SpecialtiesHealth Technology Manufactures medical and surgical devices | Health Technology |
Omni Bio Pharmaceutical, Inc.
 Omni Bio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures products for the treatment of immune-mediated inflammatory diseases | Health Technology |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Merck BioVentures | |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Willow Creek Biotech Consulting LLC |
- Stock Market
- Insiders
- Michael Kamarck
